|
1
|
Bini A, Brandolini J, Cassanelli N, Davoli
F, Dolci G, Sellitri F and Stella F: Typical and atypical pulmonary
carcinoids: our institutional experience. Interact Cardiovasc
Thorac Surg. 7:415–418. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Travis WD, Brambilla E, Müller-Hermelink
HK and Harris CC: WHO Classification of Tumors: Pathology and
Genetics of Tumours of the Lung, Pleura,Thymus and Heart. IARC
Press; Lyon: 2004
|
|
3
|
Travis WD, Rush W, Flieder DB, Falk R,
Fleming MV, Gal AA and Koss MN: Survival analysis of 200 pulmonary
neuroendocrine tumors with clarification of criteria for atypical
carcinoid and its separation from typical carcinoid. Am J Surg
Pathol. 22:934–944. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hage R, de la Rivière AB, Seldenrijk CA
and van den Bosch JM: Update in pulmonary carcinoid tumors: a
review article. Ann Surg Oncol. 10:697–704. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jeung MY, Gasser B, Gangi A, et al:
Bronchial carcinoid tumors of the thorax: spectrum of radiologic
findings. Radiographics. 22:351–365. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Debelenko LV, Brambilla E, Agarwal SK, et
al: Identification of MEN1 gene mutations in sporadic carcinoid
tumors of the lung. Hum Mol Genet. 6:2285–2290. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lemos MC and Thakker RV: Multiple
endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations
reported in the first decade following identification of the gene.
Hum Mutat. 29:22–32. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Travis WD, Rush W, Flieder DB, Falk R,
Fleming MV, Gal AA and Koss MN: Bronchopulmonary neuroendocrine
tumors. Cancer. 113:5–21. 2008. View Article : Google Scholar
|
|
9
|
Jiao Y, Shi C, Edil BH, et al: DAXX/ATRX,
MEN1, and mTOR pathway genes are frequently altered in pancreatic
neuroendocrine tumors. Science. 331:1199–1203. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Corbo V, Dalai I, Scardoni M, et al: MEN1
in pancreatic endocrine tumors: analysis of gene and protein status
in 169 sporadic neoplasms reveals alterations in the vast majority
of cases. Endocr Relat Cancer. 17:771–783. 2010. View Article : Google Scholar
|
|
11
|
Kim H, Lee JE, Cho EJ, Liu JO and Youn HD:
Menin, a tumor suppressor, represses JunD-mediated transcriptional
activity by association with an mSin3A-histone deacetylase complex.
Cancer Res. 63:6135–6139. 2003.PubMed/NCBI
|
|
12
|
Hughes CM, Rozenblatt-Rosen O, Milne TA,
et al: Menin associates with a trithorax family histone
methyltransferase complex and with the hoxc8 locus. Mol Cell.
13:587–597. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yokoyama A, Wang Z, Wysocka J, et al:
Leukemia protooncoprotein MLL forms a SET1-like histone
methyltransferase complex with menin to regulate Hox gene
expression. Mol Cell Biol. 24:5639–5649. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Pelosi G, Scarpa A, Puppa G, et al:
Alteration of the E-cadherin/β-catenin cell adhesion system is
common in pulmonary neuroendocrine tumors and is an independent
predictor of lymph node metastasis in atypical carcinoids. Cancer.
103:1154–1164. 2005.
|
|
15
|
Clavel CE, Nollet F, Berx G, et al:
Expression of the E-cadherin/β-catenin complex in lung
neuroendocrine tumours. J Pathol. 194:20–26. 2001.
|
|
16
|
Leotlela PD, Jauch A, Holtgreve-Grez H and
Thakker RV: Genetics of neuroendocrine and carcinoid tumours.
Endocr Relat Cancer. 10:437–450. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhuang Z, Vortmeyer AO, Pack S, et al:
Somatic mutations of the MEN1 tumor suppressor gene in sporadic
gastrinomas and insulinomas. Cancer Res. 57:4682–4686.
1997.PubMed/NCBI
|
|
18
|
Catalano T, Curia MC, Aceto G, et al:
Mutations in the p53 and Ki-ras genes, microsatellite instability
and site of tumor origin in colorectal cancer. Oncol Rep.
14:625–631. 2005.PubMed/NCBI
|
|
19
|
Mahdavinia M, Bishehsari F, Verginelli F,
et al: P53 mutations in colorectal cancer from northern Iran:
Relationships with site of tumor origin, microsatellite instability
and K-ras mutations. J Cell Physiol. 216:543–550. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ng PC and Henikoff S: Accaounting for
human polymorphisms predicted to affect protein function. Genome
Res. 2:436–446. 2002.PubMed/NCBI
|
|
21
|
Petitjean A, Mathe E, Kato S, Ishioka C,
Tavtigian SV, Hainaut P and Olivier M: Impact of mutant p53
functional properties on TP53 mutation patterns and tumor
phenotype: lessons from recent developments in the IARC TP53
database. Hum Mutat. 28:622–629. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Bazzi W, Renon M, Vercherat C, et al: MEN1
missense mutations impair sensitization to apoptosis induced by
wild-type menin in endocrine pancreatic tumor cells.
Gastroenterology. 135:1698–1709. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vogelstein B, Fearon ER, Hamilton SR, et
al: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Cho KR and Vogelstein B: Genetic
alterations in the adenomacarcinoma sequence. Cancer. 70:1727–1731.
1992. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Goh HS, Yao J and Smith DR: p53 point
mutation and survival in colorectal cancer patients. Cancer Res.
55:5217–5221. 1995.PubMed/NCBI
|
|
26
|
Sugio K, Osaki T, Oyama T, et al: Genetic
alteration in carcinoid tumors of the lung. Ann Thorac Cardiovasc
Surg. 9:149–154. 2003.PubMed/NCBI
|
